380 filings
Page 8 of 19
8-K
a0hf1
17 Jun 20
PAVmed to Join the Russell 2000® and Russell 3000® Indexes
9:30am
8-K
c1rul
15 Jun 20
Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor
4:05pm
8-K
3h4ltdo a5yfg
11 Jun 20
PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard™ Esophageal DNA Test
9:30am
8-K
apbx0mfn t4b
3 Jun 20
Regulation FD Disclosure
9:30am
8-K
t4v9f 5qkrhing8
21 May 20
PAVmed Reports Preliminary First Quarter 2020 Financial Results and Provides Business Update
4:46pm
8-K
x5c15r78m5
15 May 20
Other Events
6:23am
D
fjnqhh9g xyn0xtsog
1 May 20
$4.11M in debt / options / securities to be acquired, sold $4.11M, 1 investor
4:31pm
8-K
2o0s qq7y3m5o3
1 May 20
Entry into a Material Definitive Agreement
9:25am
EFFECT
q22qvuu10knhzisw1xmo
29 Apr 20
Notice of effectiveness
12:15am
424B3
xwoi2e 1g598jt
28 Apr 20
Prospectus supplement
4:06pm
CORRESP
8fsu5kgfydo4uitmm
24 Apr 20
Correspondence with SEC
12:00am
8-K
ufaovua98p
21 Apr 20
PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device
9:30am
CORRESP
2h9bx2p b3jd5dv
20 Apr 20
Correspondence with SEC
12:00am
CORRESP
4f3a1
15 Apr 20
Correspondence with SEC
12:00am
8-K
eco08ds8v1
9 Apr 20
PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update
5:27pm